RxDoctor Payments Data

Hitesh Raheja

Cardiovascular Disease · Passaic, NJNPI 1285049171

Payments from drug & device makers

$18,946in general payments, 2019–2025

Across 355 payments — averaging $53.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Abbott$5K
  • Philips North America LLC$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$864
  • Boston Scientific$765
  • Edwards Lifesciences$691
  • plus $3K from 30 others

What the payments were for

  • Travel & lodging$6,64235%
  • Food & beverage$11,76562%
  • Education$5393%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,946 in reported general payments places this provider in the 85th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$61,148
Medicare patients
220
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate145$1,371
Rosuvastatin Calcium27$137
Metoprolol Succinate14$77

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Passaic

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →